Were still figuring out exactly how these GLP-1 agonists affect stem cells and fat compartments
These side effects have prompted numerous individuals to file lawsuits, arguing that Novo Nordisk failed to adequately warn users of these potential risks
Usage of GLP-1s is growing: posting 12.4% in fall 2025, up from 5.8% in early 2024, according to Gallup
How soon will I notice results with Compounded Liraglutide
01 Jun 5 Signs Youre a Good Candidate for GLP-1 Weight Loss Medication Medically reviewed by Elyssa Blissenbach, MD Board Certified, American Boards of Internal Medicine & Obesity Medicine Licensed to practice in FL, GA, SC, AL, VA, NC NPI #1881601714 Last reviewed: 2026-06-12 GLP-1 medications like semaglutide and tirzepatide have changed whats possible for medical weight loss, but they are not the right tool for everyone